AngioDynamics, Inc. (ANGO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-138.7%

-$4.55

vs $11.76 price

Levered DCF

$3.83

After debt service

Piotroski score

5 / 9

Average

Altman Z-score

2.38

Grey zone

Rating

C+

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	-12.4×	-12.29×	-1.37×	-7.11×	-28.87×	-28.65×	-2.38×	11.46×
P/B	2.65×	2.28×	1.23×	0.99×	1.8×	2.05×	0.86×	1.15×
P/S	1.42×	1.43×	0.83×	1.1×	2.42×	3.09×	1.49×	1.96×
EV / EBITDA	818×	214.21×	-29.72×	32.27×	69.23×	-94.07×	-2.65×	37.68×
Gross margin	54.6%	53.9%	50.9%	51.4%	52.4%	53.9%	56.9%	43.4%
Operating margin	-12.5%	-13.7%	-63.3%	-15.1%	-9.0%	-12.1%	-63.3%	-2.6%
Net margin	-11.5%	-11.6%	-60.7%	-15.5%	-8.4%	-10.8%	-63.1%	17.1%
Current ratio	2.19×	2.21×	2.12×	1.95×	1.93×	2.45×	2.97×	4.3×
Debt / equity	0×	0.06×	0.02×	0.17×	0.08×	0.05×	0.09×	0.22×
Interest coverage	-133.54×	0×	0×	-18.94×	-41.38×	-40.98×	-184.23×	-1.84×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	-21.5%	-18.6%	-89.7%	-13.9%	-6.3%	-7.2%	-36.6%	10.0%
Return on invested capital	-20.7%	-19.4%	-80.1%	-10.6%	-5.2%	-6.1%	-30.4%	-0.9%
Return on assets	-13.8%	-12.1%	-58.0%	-9.8%	-4.8%	-5.6%	-28.0%	7.3%
Free cash flow yield	0.1%	-3.5%	-13.4%	-1.1%	-1.5%	2.1%	-5.6%	4.9%
Earnings yield	-8.1%	-8.1%	-72.7%	-14.0%	-3.5%	-3.5%	-42.3%	8.7%
Enterprise value	$399.2M	$372.3M	$182.2M	$393.4M	$770.7M	$872.5M	$380.4M	$613.2M
Net debt / EBITDA	-110.38×	-26.32×	11.63×	1.64×	0.45×	3.04×	0.09×	-5.6×
Cash conversion cycle (days)	108	132	116	90	122	126	178	99